This company has been marked as potentially delisted and may not be actively trading.

LAVA Therapeutics (LVTX) Stock Forecast & Price Target

Get the Latest News and Ratings for LVTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LVTX Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$1.37	$1.37	$1.37	$3.17
Forecasted Upside	-21.26% Downside	-21.26% Downside	-21.26% Downside	166.11% Upside
Consensus Rating	Reduce	Reduce	Reduce	Hold

LVTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LVTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

LAVA Therapeutics Stock vs. The Competition

Type	LAVA Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	1.75	2.30	2.52
Consensus Rating	Reduce	Hold	Moderate Buy
Predicted Upside	-21.26% Downside	938.23% Upside	14.74% Upside
News Sentiment Rating	Neutral News See Recent LVTX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/8/2025	Weiss Ratings Not Rated		Reiterated Rating	Sell (D-)
8/5/2025	HC Wainwright 3 of 5 stars	Arthur He 5 of 5 stars	Lower Target	Neutral	$1.50 ➝ $1.24	-17.61%
8/5/2025	Jefferies Financial Group 2 of 5 stars	Roger Song 5 of 5 stars	Downgrade	Buy ➝ Hold	$3.00 ➝ $1.50	+2.04%
5/15/2025	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reni Benjamin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Perform
12/12/2024	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:34 AM ET.

LVTX Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for LAVA Therapeutics is $1.37, with a high forecast of $1.50 and a low forecast of $1.24.
: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LAVA Therapeutics in the last twelve months. There is currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" LVTX shares.
: According to analysts, LAVA Therapeutics's stock has a predicted downside of -21.26% based on their 12-month stock forecasts.
: Analysts like LAVA Therapeutics less than other "medical" companies. The consensus rating for LAVA Therapeutics is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how LVTX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With LAVA Therapeutics Recommendations

This page (NASDAQ:LVTX) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.